UTRS (Minerva Surgical) Common Stock: $0.01 Mil (As of Sep. 2023)


What is Minerva Surgical Common Stock?

Minerva Surgical UTRS -99.00% Common Stock is $0.01 Mil as of Sep. 2023.

Minerva Surgical's quarterly common stock increased from Mar. 2023 ($0.18 Mil) to Jun. 2023 ($0.18 Mil) but then declined from Jun. 2023 ($0.18 Mil) to Sep. 2023 ($0.01 Mil).

Minerva Surgical's annual common stock increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.03 Mil) and increased from Dec. 2021 ($0.03 Mil) to Dec. 2022 ($0.03 Mil).

Minerva Surgical Common Stock Historical Data

* Premium members only.

The historical data trend for Minerva Surgical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Surgical Common Stock Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Common Stock
0.00 0.00 0.03 0.03

Minerva Surgical Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.18 0.18 0.01

Minerva Surgical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.01 Mil mean?
Minerva Surgical (UTRS) has a Common Stock of $0.01 Mil as of Sep. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Minerva Surgical and its competitors.
Is Minerva Surgical's Common Stock too high?
Minerva Surgical's current Common Stock is $0.01 Mil.
How does Minerva Surgical's Common Stock compare to PAVM and ELUT?
Minerva Surgical's Common Stock of $0.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Minerva Surgical and its competitors. Minerva Surgical's current Common Stock is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Surgical stock overvalued right now?
Minerva Surgical (UTRS) has a current Common Stock of $0.01 Mil. The current Common Stock is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Minerva Surgical (UTRS), the current Common Stock is $0.01 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Surgical Business Description

Address 4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.